Imcyse SA, corporate

Imcyse SA,

13.01.2022 - 13:03:13

Imcyse SA: Imcyse Reports Positive Immune Response from Interim Analysis of Phase 2 IMPACT Type 1 Diabetes Study

Tel.: +1 212-698-8698

For Media Inquiries: MC Services AG Anne Hennecke / Julia Bittner Mail: Tel.: +49 (0) 211-529-252-28

13.01.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at